Polymeric Membranes for Artificial Endosymbionts: PolyMAE

Programme(s): H2020-EU.1.3.2. - Nurturing excellence by means of cross-border and cross-sector mobility
Topic(s): MSCA-IF-2020 - Individual Fellowships
Call for proposal: H2020-MSCA-IF-2020
Funding Scheme: MSCA-IF-EF-ST - Standard EF

Grant agreement ID: 101032493

Objective
Synthetic biology has constantly been expanding its reach, aiming to develop whole genetic circuits and metabolic pathways, which require laborious genetic engineering. Often, such pathways derive from other organisms and must be tweaked to fit the host’s molecular biology, adding to the complexity of the task. However, nature has already witnessed the integration of whole prokaryotic organisms into eukaryotic hosts, where they are integrated as endosymbionts creating new combinations that live with mutual benefit. In evolutionary history, this phenomenon was at the origin of organelles such as mitochondria and chloroplasts, which added their own metabolism to their hosts. To achieve a more generalized framework, where any prokaryote can enter endosymbiosis with any eukaryote, we need to induce the uptake and retention of the guest by the eukaryotic host. A way forward will be by masking the guests with biocompatible polymers, either pre-formed, or synthesized by the bacterium itself. The project proposed herein offers a novel technique for the the encapsulation of prokaryotes into biocompatible shells, creating a new strategy for the straightforward production of bio-orthogonal, artificial endosymbionts. After the formation of the polymer shell around bacteria, they will be endocytoted by eukaryotes, thus expanding the biochemical potentialities of cells, revolutionizing the possibilities of synthetic biology, acting as true artificial organelles. This breakthrough will allow the functional insertion whole genomes into the host cells and the combination of micro-organisms, which will have implications in medicinal, industrial and environmental biotechnology. It will lead to the creation of complex, semi-synthetic hybrid organisms able to perform a vast variety of non-natural biotransformations. In line with the 2020 Work Programme, it will open up several diverse possibilities that will benefit European and global industries.